West Pharmaceutical Services Operating Income 2010-2023 | WST

West Pharmaceutical Services annual/quarterly operating income history and growth rate from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • West Pharmaceutical Services operating income for the quarter ending December 31, 2023 was $0.161B, a 24.06% increase year-over-year.
  • West Pharmaceutical Services operating income for the twelve months ending December 31, 2023 was $676M, a 7.9% decline year-over-year.
  • West Pharmaceutical Services annual operating income for 2023 was $0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services annual operating income for 2022 was $0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services annual operating income for 2021 was $0.752B, a 84.89% increase from 2020.
West Pharmaceutical Services Annual Operating Income
(Millions of US $)
2023 $676
2022 $734
2021 $752
2020 $407
2019 $297
2018 $240
2017 $226
2016 $195
2015 $129
2014 $182
2013 $162
2012 $135
2011 $110
2010 $91
2009 $98
West Pharmaceutical Services Quarterly Operating Income
(Millions of US $)
2023-12-31 $161
2023-09-30 $177
2023-06-30 $183
2023-03-31 $155
2022-12-31 $130
2022-09-30 $186
2022-06-30 $228
2022-03-31 $190
2021-12-31 $184
2021-09-30 $181
2021-06-30 $211
2021-03-31 $176
2020-12-31 $116
2020-09-30 $99
2020-06-30 $104
2020-03-31 $88
2019-12-31 $78
2019-09-30 $67
2019-06-30 $81
2019-03-31 $71
2018-12-31 $66
2018-09-30 $61
2018-06-30 $60
2018-03-31 $53
2017-12-31 $60
2017-09-30 $63
2017-06-30 $42
2017-03-31 $61
2016-12-31 $53
2016-09-30 $51
2016-06-30 $61
2016-03-31 $30
2015-12-31 $45
2015-09-30 $-4
2015-06-30 $39
2015-03-31 $48
2014-12-31 $45
2014-09-30 $44
2014-06-30 $54
2014-03-31 $39
2013-12-31 $37
2013-09-30 $40
2013-06-30 $43
2013-03-31 $43
2012-12-31 $32
2012-09-30 $26
2012-06-30 $36
2012-03-31 $42
2011-12-31 $27
2011-09-30 $26
2011-06-30 $28
2011-03-31 $29
2010-12-31 $6
2010-09-30 $25
2010-06-30 $31
2010-03-31 $29
2009-12-31 $22
2009-09-30 $26
2009-06-30 $29
2009-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $28.420B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.447B 18.86
Becton Dickinson (BDX) United States $69.880B 20.29
Cardinal Health (CAH) United States $27.145B 16.32
Align Technology (ALGN) United States $24.029B 48.55
Cooper (COO) United States $20.021B 30.30
Labcorp (LH) United States $17.957B 15.34
Henry Schein (HSIC) United States $9.366B 16.20
DENTSPLY SIRONA (XRAY) United States $6.739B 17.76
Merit Medical Systems (MMSI) United States $4.221B 24.22
Patterson (PDCO) United States $2.423B 11.60
CONMED (CNMD) United States $2.373B 22.34
STAAR Surgical (STAA) United States $1.759B 55.38
Atrion (ATRI) United States $0.769B 39.63
Lifevantage (LFVN) United States $0.080B 12.88
Pro-Dex (PDEX) United States $0.060B 22.96
Biolase (BIOL) United States $0.005B 0.00